BioCentury | Oct 9, 2020
Emerging Company Profile

A2: targeting lost genetic material to distinguish tumors from normal cells

...Column Group, Vida Ventures, Samsara BioCapital, Nextech Invest, Casdin Capital, Euclidean Capital, UC Investments, and Hartford HealthCare...
BioCentury | Jun 24, 2020
Finance

June 23 Quick Takes: Illumina selects first biotechs for U.K. accelerator; plus updates from the NASDAQ IPO queue, and venture rounds for Surrozen, Tara

...C to bring two Wnt-modulating antibodies to the clinic. Existing investors including The Column Group, Hartford Healthcare...
BioCentury | Aug 9, 2019
Financial News

ORIC raises $55M to fund trials in drug-resistant cancers

...Hughes Medical Institute. Arrowmark and Invus Opportunities led the series D round. Fellow new investors Hartford HealthCare...
BioCentury | Mar 14, 2019
Financial News

TCG again backs Surrozen in $50M series B

...for the series B along with undisclosed individual existing investors. New investors include Horizons Ventures, Hartford HealthCare...
...R-Spondin; WNT - Wingless-type MMTV integration site family Mark Zipkin, Staff Writer NS Investment Surrozen Inc. The Column Group Hartford HealthCare...
Items per page:
1 - 4 of 4
BioCentury | Oct 9, 2020
Emerging Company Profile

A2: targeting lost genetic material to distinguish tumors from normal cells

...Column Group, Vida Ventures, Samsara BioCapital, Nextech Invest, Casdin Capital, Euclidean Capital, UC Investments, and Hartford HealthCare...
BioCentury | Jun 24, 2020
Finance

June 23 Quick Takes: Illumina selects first biotechs for U.K. accelerator; plus updates from the NASDAQ IPO queue, and venture rounds for Surrozen, Tara

...C to bring two Wnt-modulating antibodies to the clinic. Existing investors including The Column Group, Hartford Healthcare...
BioCentury | Aug 9, 2019
Financial News

ORIC raises $55M to fund trials in drug-resistant cancers

...Hughes Medical Institute. Arrowmark and Invus Opportunities led the series D round. Fellow new investors Hartford HealthCare...
BioCentury | Mar 14, 2019
Financial News

TCG again backs Surrozen in $50M series B

...for the series B along with undisclosed individual existing investors. New investors include Horizons Ventures, Hartford HealthCare...
...R-Spondin; WNT - Wingless-type MMTV integration site family Mark Zipkin, Staff Writer NS Investment Surrozen Inc. The Column Group Hartford HealthCare...
Items per page:
1 - 4 of 4